MedPath

The German version of the Chelsea Critical Care Physical Assessment tool” (CPAx): reliability and validity in the critically ill patient

Conditions
Intensive Care Unit Acquired Weakness (ICUAW)
G62.80
G72.80
Registration Number
DRKS00012983
Lead Sponsor
niversitätsklinik für Intensivmedizin,Inselspital, Universitätsspital Bern
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age: = 18 Jahre, intensive care stay with mechanical ventilation = 72h, sufficient command of German, written consent to participate in the study (proxy or if possible by the patient)

Exclusion Criteria

Scheduled discharge in the next 24 hours, new neurological admission diagnosis with functional deficits (including status after reanimation), expected palliative care, known pregnancy, pre-existing mental disability, living in a care facility or wheelchair user, external intensive care unit stay of >3 days or re-admission

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Construct validity: We expect a high correlation of the CPAx (Chelsea Critical Care Physical Assessment tool) with the prevalence of a ICUAW (Intensive Care Unit Acquired Weakness). Consequently, we test the hypothesis, that the CPAx correlates with the diagnostic tool for ICUAW: the Medical Research Council sum score.
Secondary Outcome Measures
NameTimeMethod
2. inter-rater reliability of the CPAx (Chelsea Critical Care Physical Assessment Tool) (min. n=20, randomised, patients will be assessed by two to three raters at the bedside (blinded assessors)<br>3. internal consistency of each CPAx (Chelsea Critical Care Physical Assessment Tool) item (Cronbachs alpha)<br>4. prognostic validity for a positive outcome, defined as a return to home 90 days after critical care discharge<br>5. responsivity (ceiling and floor effects, minimal clinical important difference)
© Copyright 2025. All Rights Reserved by MedPath